Drug price history · CMS NADAC read 11 November 2026

What have pharmacies paid for Paliperidone since 2013?

What pharmacies pay, not what you pay. Paliperidone has 4 products in the CMS NADAC survey, 4 products with year-end prices in more than one year. NADAC is what pharmacies pay to acquire a drug, not what a patient is charged. Paliperidone ER 3 MG Tablet: $22.81 per unit at the 2015 survey and $1.01 at 2026 (−96%).
Not medical or financial advice. This page reports what pharmacies pay to acquire a drug, from the CMS NADAC survey. It is not what you will be charged, and it says nothing about which medicine is right for you. Ask your pharmacist or prescriber.
Paliperidone4 products in NADAC
4products with a price history
  1. Paliperidone has 4 products in the CMS NADAC survey, 4 products with year-end prices in more than one year. NADAC is what pharmacies pay to acquire a drug, not what a patient is charged.
  2. Between each product's first and latest year-end survey, 4 products cost pharmacies less and none costs more, by more than 5 percent, per unit as CMS states it.
  3. This is a per-unit acquisition cost, not a retail price, a copay or an insurer's price, and it says nothing about why a price moved.

Paliperidone ER 3 MG Tablet

Generic

$22.81 per unit at the 2015 year-end survey (5 NDCs) and $1.01 at the 2026 survey (12 NDCs): −96%.

$0$22.812015: median $22.81 per unit, 5 NDCs priced2016: median $15.49 per unit, 7 NDCs priced2017: median $12.71 per unit, 7 NDCs priced2018: median $10.81 per unit, 8 NDCs priced2019: median $9.64 per unit, 10 NDCs priced2020: median $6.88 per unit, 14 NDCs priced2021: median $5.96 per unit, 13 NDCs priced2022: median $3.46 per unit, 14 NDCs priced2023: median $1.53 per unit, 13 NDCs priced2024: median $1.42 per unit, 11 NDCs priced2025: median $1.22 per unit, 12 NDCs priced2026: median $1.01 per unit, 12 NDCs priced2015201720192021202320252026
year-end median across the NDCs pricedlowest to highest NDC
Year-end surveyMedian per unitLowest to highestNDCs priced
2015 (2015-12-30)$22.815
2016 (2016-12-28)$15.497
2017 (2017-12-27)$12.717
2018 (2018-12-26)$10.818
2019 (2019-12-25)$9.6410
2020 (2020-12-30)$6.8814
2021 (2021-12-29)$5.9613
2022 (2022-12-28)$3.4614
2023 (2023-12-27)$1.5313
2024 (2024-12-25)$1.4211
2025 (2025-12-31)$1.2212
2026 (2026-11-11)$1.0112

Paliperidone ER 6 MG Tablet

Generic

$20.29 per unit at the 2015 year-end survey (5 NDCs) and $0.979 at the 2026 survey (12 NDCs): −95%.

$0$20.292015: median $20.29 per unit, 5 NDCs priced2016: median $15.30 per unit, 7 NDCs priced2017: median $12.27 per unit, 7 NDCs priced2018: median $9.38 per unit, 8 NDCs priced2019: median $8.87 per unit, 10 NDCs priced2020: median $6.82 per unit, 14 NDCs priced2021: median $5.31 per unit, 14 NDCs priced2022: median $3.29 per unit, 14 NDCs priced2023: median $1.85 per unit, 14 NDCs priced2024: median $1.34 per unit, 11 NDCs priced2025: median $1.27 per unit, 12 NDCs priced2026: median $0.979 per unit, 12 NDCs priced2015201720192021202320252026
year-end median across the NDCs pricedlowest to highest NDC
Year-end surveyMedian per unitLowest to highestNDCs priced
2015 (2015-12-30)$20.295
2016 (2016-12-28)$15.307
2017 (2017-12-27)$12.277
2018 (2018-12-26)$9.388
2019 (2019-12-25)$8.8710
2020 (2020-12-30)$6.8214
2021 (2021-12-29)$5.3114
2022 (2022-12-28)$3.2914
2023 (2023-12-27)$1.8514
2024 (2024-12-25)$1.3411
2025 (2025-12-31)$1.2712
2026 (2026-11-11)$0.97912

Paliperidone ER 9 MG Tablet

Generic

$31.07 per unit at the 2015 year-end survey (5 NDCs) and $1.05 at the 2026 survey (10 NDCs): −97%.

$0$31.072015: median $31.07 per unit, 5 NDCs priced2016: median $23.90 per unit, 5 NDCs priced2017: median $18.71 per unit, 5 NDCs priced2018: median $14.26 per unit, 6 NDCs priced2019: median $13.78 per unit, 7 NDCs priced2020: median $10.34 per unit, 12 NDCs priced2021: median $6.99 per unit, 11 NDCs priced2022: median $3.91 per unit, 12 NDCs priced2023: median $2.82 per unit, 14 NDCs priced2024: median $1.69 per unit, 9 NDCs priced2025: median $1.41 per unit, 10 NDCs priced2026: median $1.05 per unit, 10 NDCs priced2015201720192021202320252026
year-end median across the NDCs pricedlowest to highest NDC
Year-end surveyMedian per unitLowest to highestNDCs priced
2015 (2015-12-30)$31.075
2016 (2016-12-28)$23.905
2017 (2017-12-27)$18.715
2018 (2018-12-26)$14.266
2019 (2019-12-25)$13.787
2020 (2020-12-30)$10.3412
2021 (2021-12-29)$6.9911
2022 (2022-12-28)$3.9112
2023 (2023-12-27)$2.8214
2024 (2024-12-25)$1.699
2025 (2025-12-31)$1.4110
2026 (2026-11-11)$1.0510

Paliperidone ER 1.5 MG Tablet

Generic

$19.59 per unit at the 2016 year-end survey (3 NDCs) and $0.918 at the 2026 survey (9 NDCs): −95%.

$0$19.592016: median $19.59 per unit, 3 NDCs priced2017: median $13.24 per unit, 3 NDCs priced2018: median $10.10 per unit, 4 NDCs priced2019: median $8.99 per unit, 6 NDCs priced2020: median $7.47 per unit, 7 NDCs priced2021: median $4.23 per unit, 7 NDCs priced2022: median $2.83 per unit, 8 NDCs priced2023: median $1.30 per unit, 8 NDCs priced2024: median $1.17 per unit, 8 NDCs priced2025: median $1.09 per unit, 8 NDCs priced2026: median $0.918 per unit, 9 NDCs priced201620182020202220242026
year-end median across the NDCs pricedlowest to highest NDC
Year-end surveyMedian per unitLowest to highestNDCs priced
2016 (2016-12-28)$19.593
2017 (2017-12-27)$13.243
2018 (2018-12-26)$10.104
2019 (2019-12-25)$8.996
2020 (2020-12-30)$7.477
2021 (2021-12-29)$4.237
2022 (2022-12-28)$2.838
2023 (2023-12-27)$1.308
2024 (2024-12-25)$1.178
2025 (2025-12-31)$1.098
2026 (2026-11-11)$0.9189

CMS National Average Drug Acquisition Cost, year-end surveys 2013 to 2026. A pharmacy acquisition cost, not a retail price. About NADAC.

Where does Paliperidone sit on the generic price cliff?

Paliperidone ER 3 MG Tablet: the first generic approval in its Orange Book group is dated 2015. Its year-end acquisition cost in 2026 is 4% of its first observed year-end price (2015). The median matched product, 11 years after its first generic approval, is at 21% (the middle half runs from 5% to 51%), so this product is below that middle half.

0%25%50%75%100%0 years after the first generic approval: median 100%, middle half 100% to 100%, 79 products1 years after the first generic approval: median 95%, middle half 71% to 100%, 118 products2 years after the first generic approval: median 80%, middle half 49% to 99%, 135 products3 years after the first generic approval: median 64%, middle half 36% to 90%, 142 products4 years after the first generic approval: median 55%, middle half 25% to 84%, 154 products5 years after the first generic approval: median 46%, middle half 16% to 80%, 154 products6 years after the first generic approval: median 45%, middle half 16% to 87%, 154 products7 years after the first generic approval: median 40%, middle half 14% to 71%, 153 products8 years after the first generic approval: median 32%, middle half 8% to 65%, 131 products9 years after the first generic approval: median 28%, middle half 7% to 67%, 109 products10 years after the first generic approval: median 22%, middle half 5% to 53%, 90 products11 years after the first generic approval: median 21%, middle half 5% to 51%, 79 products12 years after the first generic approval: median 16%, middle half 6% to 34%, 48 products13 years after the first generic approval: median 19%, middle half 14% to 39%, 23 productsPaliperidone ER 3 MG Tablet, 0 years after the first generic approval: 100% of its first observed price, 5 NDCs pricedPaliperidone ER 3 MG Tablet, 1 years after the first generic approval: 68% of its first observed price, 7 NDCs pricedPaliperidone ER 3 MG Tablet, 2 years after the first generic approval: 56% of its first observed price, 7 NDCs pricedPaliperidone ER 3 MG Tablet, 3 years after the first generic approval: 47% of its first observed price, 8 NDCs pricedPaliperidone ER 3 MG Tablet, 4 years after the first generic approval: 42% of its first observed price, 10 NDCs pricedPaliperidone ER 3 MG Tablet, 5 years after the first generic approval: 30% of its first observed price, 14 NDCs pricedPaliperidone ER 3 MG Tablet, 6 years after the first generic approval: 26% of its first observed price, 13 NDCs pricedPaliperidone ER 3 MG Tablet, 7 years after the first generic approval: 15% of its first observed price, 14 NDCs pricedPaliperidone ER 3 MG Tablet, 8 years after the first generic approval: 7% of its first observed price, 13 NDCs pricedPaliperidone ER 3 MG Tablet, 9 years after the first generic approval: 6% of its first observed price, 11 NDCs pricedPaliperidone ER 3 MG Tablet, 10 years after the first generic approval: 5% of its first observed price, 12 NDCs pricedPaliperidone ER 3 MG Tablet, 11 years after the first generic approval: 4% of its first observed price, 12 NDCs priced024681012years since the first generic approval
median of 200 matched productsmiddle halfeach productPaliperidone ER 3 MG Tablet

This is a pattern in matched products. It does not say the first generic caused the fall, and it does not say this product's price will follow the median. See it with other drugs.

Where can you go from this record?

Open it in the check to search another drug, or see the CMS pharmacy pricing page for what NADAC measures. To check whether a drug is in shortage, see the FDA drug shortages page.

Compiled and checked by Vincent Wesley Couey (ORCID 0009-0005-6869-308X) from the CMS pharmacy pricing page, year-end surveys 2013 to 2026 (latest 11 November 2026).